Checkpoint Therapeutics, Inc. Annual Return On Equity in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Checkpoint Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2023.
  • Checkpoint Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 292 %, a 17.4% decline year-over-year.
  • Checkpoint Therapeutics, Inc. annual Return On Equity for 2023 was 267 %.
  • Checkpoint Therapeutics, Inc. annual Return On Equity for 2022 was -3.65K %, a 2941% decline from 2021.
  • Checkpoint Therapeutics, Inc. annual Return On Equity for 2021 was -120 %, a 33.7% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 267 +3.92K Jan 1, 2023 Dec 31, 2023
2022 -3.65K -3.53K -2941% Jan 1, 2022 Dec 31, 2022
2021 -120 -30.3 -33.7% Jan 1, 2021 Dec 31, 2021
2020 -89.8 +161 +64.2% Jan 1, 2020 Dec 31, 2020
2019 -251 -79.8 -46.6% Jan 1, 2019 Dec 31, 2019
2018 -171 -68.7 -67.1% Jan 1, 2018 Dec 31, 2018
2017 -102 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.